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The Pseudomonas syringae type III effector protein avirulence protein B (AvrB) is delivered into plant cells, where it
targets the Arabidopsis RIN4 protein (resistance to Pseudomonas maculicula protein 1 [RPM1]–interacting protein). RIN4
is a regulator of basal host defense responses. Targeting of RIN4 by AvrB is recognized by the host RPM1 nucleotide-
binding leucine-rich repeat disease resistance protein, leading to accelerated defense responses, cessation of pathogen
growth, and hypersensitive host cell death at the infection site. We determined the structure of AvrB complexed with
an AvrB-binding fragment of RIN4 at 2.3 A ˚ resolution. We also determined the structure of AvrB in complex with
adenosine diphosphate bound in a binding pocket adjacent to the RIN4 binding domain. AvrB residues important for
RIN4 interaction are required for full RPM1 activation. AvrB residues that contact adenosine diphosphate are also
required for initiation of RPM1 function. Nucleotide-binding residues of AvrB are also required for its phosphorylation
by an unknown Arabidopsis protein(s). We conclude that AvrB is activated inside the host cell by nucleotide binding
and subsequent phosphorylation and, independently, interacts with RIN4. Our data suggest that activated AvrB, bound
to RIN4, is indirectly recognized by RPM1 to initiate plant immune system function.
Citation: Desveaux D, Singer AU, Wu AJ, McNulty BC, Musselwhite L, et al. (2007) Type III effector activation via nucleotide binding, phosphorylation, and host target
interaction. PLoS Pathog 3(3): e48. doi:10.1371/journal.ppat.0030048
Introduction
Many Gram-negative bacterial pathogens of plants or
animals employ type III secretion systems (TTSSs) to trans-
locate type III effector proteins into host cells [1]. Type III
effector proteins manipulate host cellular targets and signal-
ing pathways to promote the infection process in genetically
susceptible hosts [2,3]. In the plant immune system, speciﬁc
nucleotide-binding leucine-rich repeat (NB-LRR) disease
resistance proteins can monitor the homeostasis of type III
effector targets [4–6]. In several cases, when a type III effector
perturbs its target, the corresponding NB-LRR protein is
activated. NB-LRR activation leads to a complex output
including hypersensitive cell death (HR) and a suite of
cellular responses that render the plant resistant to infection
by pathogen strains expressing that type III effector.
The Arabidopsis NB-LRR protein RPM1 (resistance to
Pseudomonas maculicula protein 1) recognizes the action of
two distinct type III effector proteins, avirulence protein
Rpm1 (AvrRpm1) and avirulence protein B (AvrB), which are
found in various strains of the plant pathogen Pseudomonas
syringae [7,8]. The RPM1-interacting protein (RIN4) is re-
quired for RPM1 function triggered by either AvrRpm1 or
AvrB [9]. RIN4 physically associates in vivo with both AvrB
and AvrRpm1, and with RPM1 [9]. The presence of either
AvrRpm1 or AvrB in the plant cell leads to phosphorylation
of RIN4, although neither of the type III effectors has
sequence similarity to kinases [9]. RIN4 also interacts with,
and is required for the function of, a second NB-LRR protein,
RPS2 (resistance to P. syringae protein 2) [10,11]. The
corresponding type III effector, avirulence protein Rpt 2
(AvrRpt2), is an autoprocessed cysteine protease that is
activated by a host cyclophillin after delivery [12,13]. AvrRpt2
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RIN4 drives RPS2 activation [10,11].
One of the AvrRpt2 cleavage sites overlaps the AvrB
binding site on RIN4 [15]. Thus, at least two independent type
III effector proteins have evolved to target a small approx-
imately 30–amino acid domain on RIN4 using at least two
different biochemical mechanisms. It remains to be deter-
mined whether AvrRpm1 also targets this region of RIN4.
This region is shared among several otherwise unrelated
Arabidopsis proteins of unknown function and may represent
a common motif targeted by plant pathogens [14,15]. RPM1,
RPS2, the type III effectors, and RIN4 have been demon-
strated, or are predicted to be, localized to the inside of the
plant plasma membrane; AvrB, AvrRpm1, and RIN4 are
acylated as a requirement for this localization [11,15–17].
Despite the wealth of genetic information for AvrB, its
biochemical function remains elusive. A crystal structure of
free AvrB revealed that it adopts a novel bilobal fold with no
structural homologies to previously characterized proteins or
functional domains [18]. A small upper lobe (amino acid
residues 123 to 217) contains three alpha-helices (a5, a6, and
a7) surrounding a ﬁve-stranded antiparallel beta-sheet (b1-
b5-b4-b3-b2). A large lower lobe (residues 28 to 122 and 218
to 317) is composed strictly of alpha-helices [18]. The junction
of the two lobes forms a large solvent-accessible cleft with a
volume of over 900 A ˚ 3 that extends into the lower lobe to
form a pocket rich in conserved residues. Chimeras of AvrB
with the closely related paralog avirulence protein C (AvrC)
(which does not activate RPM1) were used to demonstrate
that the upper lobe of AvrB (residues 126 to 216) is required
for RPM1 activation [18]. The lack of sequence conservation
in the upper lobe among AvrB paralogs from various plant
pathogens that do not trigger RPM1 mediated responses (see
below) further supports this contention. In contrast, the
lower lobe and the interlobal cleft are highly conserved in
sequence among the AvrB family members. The conserved
cleft was hypothesized to be an enzymatic active site that
binds to substrate and/or cofactor [18].
In this study, we present the structure of AvrB bound to
RIN4 and we identify interacting residues in the upper lobe
of AvrB that are required for both RIN4 binding and
activation of RPM1. We also identiﬁed a highly conserved
nucleotide-binding pocket contained largely in the lower lobe
of AvrB that is also required for activation of RPM1. In
addition, phosphorylation of AvrB occurs in the presence of a
host cofactor or kinase and may represent a third prereq-
uisite for recognition by RPM1.
Results
Structure of AvrB Bound to RIN4
Previous work using gel ﬁltration and native gel electro-
phoresis demonstrated that AvrB bound a small RIN4
fragment consisting of amino acids 142 to 179 [15]. We
cocrystallized AvrB with RIN4142–176 (Figure 1A, 1C, and 1E;
Table 1). This fragment binds AvrB with afﬁnity similar to
that of the full-length protein (kd ¼ 3 lM versus 4 lMa s
determined by isothermal titration calorimetry [ITC]; see
below). Thus, essentially all of the binding energy for
interaction with AvrB is contained in RIN4142–176.T h e
structure of AvrB complexed to RIN4142–176 revealed that
the peptide forms a ‘‘Z’’ shape with the N-terminal half
contacting the upper lobe and the C-terminal half straddling
the interface between the two lobes (Figure 1A, 1C, and 1E;
Table 1). The interaction of AvrB with RIN4142–176 does not
alter the overall structure of AvrB (unpublished data). Using
this cocrystal structure, we identiﬁed residues of AvrB that
interact with RIN4142–176 and could potentially be important
for binding afﬁnity (Figure 2A and 2C). The N-terminal half
of RIN4142–176 interacts mainly through hydrophobic burial
of RIN4 W154 plus a hydrogen bond between the indole
nitrogen of RIN4 W154 and AvrB D213 (Figure 2A). RIN4
W154 is part of an AvrRpt2 cleavage site on RIN4 [14].
Additionally, AvrB T182 contacts RIN4 Y151, and AvrB V128
contacts RIN4 D155, S161, and G162.
The most extensive interactions of RIN4142–176 with AvrB
involve the C-terminal half of the RIN4 peptide. First, there is
a set of antiparallel beta-strand hydrogen-bonding interac-
tions between main-chain AvrB residues 120 to 124 (within
strand b1) and RIN4 residues 167–171. Second, there is a
hydrogen bond between the main-chain of RIN4 N170 and
the AvrB R209 guanidinium group. These interactions allow
this region of RIN4 to form an additional strand of the beta-
sheet in the upper lobe of AvrB (Figure S1). Importantly, in
forming this strand, the RIN4 T166 side-chain is directed
toward the interior of AvrB such that the hydroxyl group
hydrogen bonds with the hydroxyl group of AvrB T125, which
in turn hydrogen bonds to the imidazole ring of AvrB H217
(Figure 2C).
Above this hydrogen-bonding arrangement, the aromatic
rings of RIN4 Y165 and F169 as well as interleaving H167 are
thrust against the surface formed from the last two turns of
AvrB helix a7 (Figure 2A). This ‘‘ring-stack’’ of RIN4 spans
from the AvrB upper lobe (R209) to the interlobe boundary
(R266) (Figure 2A). These aromatic and indole side-chains
stack in a nearly parallel arrangement with each other that is
energetically very favorable. The guanidinium groups of AvrB
R209 and AvrB R266 buttress the termini of the ring-stack,
contacting RIN4 F169 and Y165, respectively, via p–p
interactions such that the guanidium groups are also almost
parallel to the three stacked aromatic rings of RIN4. In the
middle of this ring stack, AvrB Q208 forms additional contacts
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Author Summary
Many bacterial pathogens use a specialized protein ‘‘injection
needle’’ called a type III secretion system to help colonize cells of
higher organisms. The type III secretion needle attaches to a host
cell and is the delivery conduit for a variety of bacterial proteins that
act inside of the host cell. These proteins are called type III effectors.
They manipulate host cell biology in order to help the bacterial
pathogen colonize the host. We studied one type III effector from
plant pathogenic bacteria called Pseudomonas syringae.T h i s
effector, termed avirulence protein B (AvrB), is targeted to the inner
face of the plant cell plasma membrane, where it interacts with a
membrane-bound host protein called RIN4 (resistance to Pseudo-
monas maculicula protein–interacting protein). RIN4 is phosphory-
lated in the presence of AvrB and an as-yet-unknown additional host
factor. We provide a structural basis for the binding of AvrB to RIN4
and a possible mechanism of action for AvrB inside the host. AvrB
activation and its ability to bind RIN4 have evolved to help the
pathogen, yet in Arabidopsis, the AvrB-dependent phosphorylation
of RIN4 is sensed by the plant immune system, leading to a rapid
halt in pathogen growth.with RIN4 H167 (Figure 2A). AvrB Y210 may play a weak role
in RIN4142–176 binding since additional electron density from
RIN4142–176 appears to be contacting this residue (Figure 1A).
No additional electron density is observed for the last four
residues of the RIN4 peptide (sequence REER).
The C-Terminal Regions of RIN4142–176 Are Required for
Binding to AvrB
RIN4 and AvrB interact in yeast two-hybrid assays and can
be coimmunoprecipitated from plant tissue [9]. This inter-
action is direct, because both puriﬁed proteins comigrate as
an in vitro complex on native gel ﬁltration columns [15]. To
test whether the aforementioned AvrB residues are involved
in RIN4 binding (listed in Table 2), we mutated the relevant
amino acids individually to alanine. These mutants were
assayed for their ability to bind full-length RIN4 by in vitro
gel ﬁltration and/or in vivo by yeast two-hybrid assay (Table
2). In addition, the binding afﬁnity of selected AvrB mutants
and RIN4142–176 was measured by ITC (Figure 3).
The cocrystal structure revealed that the side-chains of
several AvrB upper lobe residues make contacts with the N-
terminal region of RIN4142–176. For example, D213 of AvrB
interacts with W154 within the N-terminal portion of
RIN4142–176. However, substitution of D213 to alanine did
not disrupt either binding to RIN4 or the ability to trigger
RPM1-mediated responses. The substitution of nearby resi-
dues of AvrB (i.e., V128A and T182A) also did not disrupt
binding to RIN4 or activation of RPM1 (Table 2; unpublished
data). These AvrB residues contact the N-terminal region of
RIN4142–176 that contains an AvrRpt2 cleavage [14,15]. Hence,
our data suggest AvrB and AvrRpt2 target two distinct amino
acid sequences of this short, 35–amino acid residue region of
RIN4.
In contrast, disruption of AvrB residues contacting the C
terminus of RIN4142–176 strongly affected RIN4 binding.
AvrB
T125A and AvrB
H217A were unable to bind RIN4142–176
under our ITC conditions (Figure 3). Loss of RIN4 binding
activity was not due to signiﬁcant structural disruptions, since
AvrB
T125A or AvrB
H217A were properly folded, as measured by
circular dichroism (unpublished data). Similar mutation of
AvrB residues directly supporting the side-chains of the ring-
stack also affected RIN4 binding. The single mutation
AvrB
R209A had very little effect on RIN4 binding (Table 2)
but a triple mutation of Q208, R209, and Y210 to alanine
(hereafter AvrB
QRY/AAA) signiﬁcantly lowered the afﬁnity for
RIN4 (kd ¼ 9 lM for AvrB
QRY/AAA) and destabilized the AvrB/
RIN4 complex (Figure 3 and Table 2). Overall, two regions of
the upper lobe make distinct and functional contacts with the
C-terminal region of RIN4142–176: (1) AvrB residues Q208,
R209, and Y210, which directly support the side-chains of the
ring-stack, and (2) AvrB residues T125 and H217, which
interact with RIN4 T166, between Y165 and H167 of the ring-
stack.
RIN4-Interacting Residues of AvrB Are Required to
Activate RPM1
AvrB induces phosphorylation of RIN4 [9], but it remained
unclear whether AvrB must interact with RIN4 to trigger
RPM1-mediated disease resistance and HR. We reasoned that
if the RIN4–AvrB interaction is a prerequisite for RPM1-
mediated HR or disease resistance, then AvrB mutants that
do not bind to RIN4 should not trigger either phenotype. The
preceding experiments identiﬁed AvrB mutants that varied in
binding afﬁnity to RIN4 (Figure 3 and Table 2). We expressed
these avrB alleles in Pseudomonas syringae pv. tomato (Pto)
DC3000. All of the AvrB alleles that exhibited altered
function, as described below, were expressed at essentially
normal levels in P. syringae (Figure S2D). Arabidopsis leaves
were infected with Pto DC3000 strains expressing wild-type
AvrB, each AvrB mutant, or an empty vector and assessed for
RPM1-mediated HR using both trypan blue as a qualitative
measure and the leakage of cellular ions into media and
Figure 1. Structures of AvrB Complexed with RIN4142–176 and ADP
(A) Difference electron density (Fo   Fc) from AvrB/RIN4142–176 crystals
centered on the C-terminal b-strand of RIN4142–176 (green sticks)
following molecular replacement with two AvrB molecules (PDB 1NH1).
(B) Difference electron density (Fo   Fc) from AvrB crystals soaked with
ADP following molecular replacement with 1 AvrB (PDB 1NH1).
For (A) and (B), densities are contoured at 2 and 4 r, respectively.
(C and D) Ribbon diagrams of the AvrB/RIN4142–176 and AvrB/ADP
complexes, respectively. AvrB helices, strands, and loops are red, blue,
and cyan, respectively, and the RIN4142–176 ribbon is green. The overall
structures are similar, and the different AvrB N and C termini between
them likely reflects differences in their packing interfaces.
(E and F) Surface representations of AvrB in the AvrB/RIN4142–176 and
AvrB/ADP complexes, respectively. (E) RIN4142–176 is shown as a ribbon
diagram with the side-chains of W154, Y165, T166, H167, and F169
represented as spheres to emphasize the surface grooves and
concavities in AvrB that buries these residues. Note that the views
represented in (C) and (E) and in (D) and (F) are identical.
doi:10.1371/journal.ppat.0030048.g001
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quantitative measure (Figures 4A, 4B, S2A, and S2C). We also
quantiﬁed the RPM1-mediated restriction of pathogen
growth for selected AvrB mutants (Figure 4C). The results
of these functional tests are summarized on the structures in
Figure 2A and 2C.
V128, T182, and D213 are in a region of the AvrB upper
lobe that is not required for interaction with RIN4 (Table 2).
Unsurprisingly, these mutants have no effect on the ability of
AvrB to activate RPM1 (Figure S2). The residues of AvrB that
directly support the ring-stack of RIN4, especially R209 and
Y210 (Figure 3 and Table 2), are more important for complex
formation. Thus, while AvrB
R209A bound RIN4 (Table 2), and
only marginally diminished RPM1-mediated HR in both
assays (Figure 4A and 4B), disruption of several of the ring-
stack interactions in AvrB
QRY/AAA drastically diminished
RIN4 binding activity in vitro (Figure 3; Table 2) and resulted
in signiﬁcantly reduced RPM1-mediated HR (Figure 4A and
4B). These levels of altered HR correlated with slightly
reduced RPM1-mediated restriction of bacterial growth. Pto
DC3000(avrB
R209A) and Pto DC3000(avrB
QRY/AAA) grew in
planta more than bacteria expressing wild-type avrB (Figure
4C).
Furthermore, mutations that disrupt the hydrogen bonding
between AvrB T125 and H217 and RIN4 T166 (Figure 2A and
2C) eliminated or greatly reduced binding to RIN4 and the
ability of these AvrB mutants to trigger RPM1 function (Table
2 and Figures 3 and 4). Translocation assays conﬁrmed that
AvrB
T125A was delivered into Arabidopsis cells (as are other
loss-of-function AvrB alleles described here; Figure S3 and
Table 2). Therefore, interactions that either directly or
indirectly support the ring-stack of RIN4 are a major
determinant for complex formation. Taken together, these
results strongly suggest that binding of RIN4 by AvrB is a
prerequisite for its ability to efﬁciently activate RPM1.
AvrB Possesses a Nucleotide-Binding Domain Required for
Function
The AvrB
R266A mutation was unable to trigger RPM1
function (Figure 4). The AvrB structure contains a cavity in
the large lobe [18]. AvrB R266 lies at the interlobe boundary
between the major RIN4-binding groove and this cavity
(Figure 2). We hypothesized that this large cavity, rich in
residues that are highly conserved across the AvrB protein
family (see below), could serve as a binding site for a cofactor
for AvrB activity. Because the presence of AvrB renders RIN4
marginally hyperphosphorylated [9], we wondered whether
AvrB is an atypical kinase. We therefore examined binding to
nucleotides, including adenosine triphosphate (ATP), adeno-
sine diphosphate (ADP), guanosine diphosphate, and non-
hydrolyzable ATP and guanosine diphosphate analogs, by
soaking these into AvrB crystals. We found that crystallized
AvrB could bind ADP within the lower lobe pocket of the
large cavity (referred to as the ADP pocket; Figures 1B, 1D,
1F, 2B, and 2D; Table 1). We observed only weak density
corresponding to other nucleotides in the lower lobe pocket
(unpublished data). Signiﬁcant interactions with ADP involve
AvrB residues Y65, R99, and R266 (Figure 2B and 2D). Y65
stacks below the adenine ring and hydrogen bonds to the 2-
OH group of the ribose, while R99 and R266 form salt bridges
with the alpha- and beta-phosphates, respectively. N62 and
F113 also contact the adenine base and phosphates, respec-
tively (Figure 2B and 2D). F113 also appears to contribute to
proper positioning of R99 and R266. The conserved AvrB
residues Y131 and D297 located at the interlobe boundary are
approximately 4 A ˚ from ADP and appear to contact it only
via bridging water molecules.
Table 1. X-Ray Data Collection and Refinement Statistics
Structure AvrB/RIN4142–176 AvrB/ADP
Data collection Wavelength (A ˚) 1.0000 1.5418
Resolution (A ˚) 50.0 to 2.15 99.0 to 2.2
Total observations 118,397 73,769
Unique reflections 24,071 29,016
Completeness (%)
a 80.4 (32.0) 88.8 (72.7)
I/r
b 28.0 (2.63) 11.0 (2.6)
Rsym
c 9.3 (31.8) 10.9 (43.9)
Refinement and model statistics Resolution (A ˚) 20 to 2.3 20 to 2.4
Reflections (working/test) 26,385/1,273 20,648/999
Rwork
d (%) 21 23.2
Rfree
e (%) 26 25.4
Mean B factor (overall, A ˚2) 32.2 52.8
Wilson B factor (A ˚2) 36.2 45.1
R.M.S. deviations Bond lengths (A ˚) 0.007 0.007
Bond angles (8) 1.2 1.3
Ramachandran plot Percent in most favored regions 92.2 90.4
Percent in additional allowed regions 7.4 9.3
Percent in disallowed regions 0.0 0.0
aValues in parentheses refer to the highest resolution shell.
bI/r ¼ mean signal to noise, where I is the integrated intensity of a measured reflection, and r is the estimated error in measurement.
cRsym ¼ 100 3 Rj1   ,I.j/RI, where I is the integrated intensity of each measured reflection.
dRwork ¼ RjFo   Fcj/RFo, where Fo and Fc are defined as the observed and calculated structure factor amplitudes.
eRfree is calculated as defined by Rwork using test set reflections (5% of the total).
doi:10.1371/journal.ppat.0030048.t001
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Y65A,A v r B
R99A,
andAvrB
R266AresultedincompletelossofAvrB-inducedRPM1
function (Figure 4). Mutation of ADP-interacting residues
AvrB
N62A and AvrB
F113A resulted in partial losses of RPM1-
mediated HR (Figure S2B and S2C). Surprisingly, mutations
that appear to contact ADP only via water bridges, AvrB
Y131A
and AvrB
D297A, also abrogated RPM1-mediated HR and
bacterial growth restriction (Figure 4). Thus, all of the AvrB
loss-of-function mutants in the ADP binding cavity eliminated
the initiation of RPM1 function. We note, however, that they
are each produced and properly folded (Figure S2D and
circular dichroism, unpublished data) and translocated into
host cells (Figure S3). Although AvrB
Y65A and AvrB
D297A failed
to bind RIN4 in ITC (Figure 3), they, along with AvrB
R99A,d i d
bind RIN4 in yeast two-hybrid assay, gel ﬁltration, or both
(Table 2). We discuss these data further below.
AvrB Is Phosphorylated in the Host Cell
Since RIN4 phosphorylation is induced by AvrB, it was
hypothesized that AvrB may possess kinase activity. However,
we detected no AvrB-dependent phosphorylation of RIN4 or
RIN4142–176 using in vitro radiolabeling experiments in the
presence or absence of Arabidopsis extracts. We also found no
evidence for in vitro autophosphorylation of AvrB (Figure
5A). We did, however, observe phosphorylation of AvrB in the
presence of wild-type Arabidopsis extracts (Figure 5A). AvrB
Figure 2. Close-Up Views of the AvrB/RIN4142–176 and AvrB/ADP Interfaces
(A and B) A semitransparent representation of the AvrB surface showing selected AvrB side-chains that contact RIN4142–176 [green in (A)] and ADP in (B).
Atoms of ADP and RIN4142–176 side-chains are colored by type: C (green), N (blue), O (red), and P (pink). AvrB side-chains are coded by atom type; C
(light blue), N (blue), and O (red). Positive and negative surface charges of the indicated AvrB side-chains are color coded blue and red, respectively. Text
for AvrB residues that were mutated and tested for their ability to trigger RPM1 function are color coded as follows: red, full loss of function; yellow,
partial loss of function; black, no loss of function.
(C and D) A close-in semitransparent representation of the AvrB surface highlighting the functional requirement (complete, red; partial, yellow) for AvrB
amino acids in triggering RPM1 function. Relevant side-chains and surfaces of AvrB residues are displayed as stick representations with color-coded
labels as in (A) and (B). Stick representations of residues from RIN4142–176 are labeled green in (C), and a stick representation of ADP is highlighted in (D).
doi:10.1371/journal.ppat.0030048.g002
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AvrB Structural
Features
AvrB
Mutation
HR
Trypan
HR Ion
Leakage
RIN4
Binding
ITC
RIN4 Binding
Gel Filtration
RIN4
Binding
Y2H
Translocation
Assay
Contact Details
RIN4142–176
contact surface
T125A         þ T166 H-bond
V128A þþ NA NA þ NA D155, G163 contact
Q208A 6 þ NA þþ NA H167 contact
R209A 66 NA þþ NA F169 contact
QRY/AAA 66 6   NA NA H167, F169, and C-term contact
D213A þþ NA NA NA NA W154 H-bond
H217A 66    NA NA T166 H-bond
Q265A þþ NA NA þ NA I168 contact
T182A þþ NA NA þ NA Y151 contact
R266A
a      þ NA þ Y165 contact (RIN4); b-Phosphate H-bond
(ADP)
L109A þþ NA NA þ NA Y165 contact (RIN4); position AvrB R266
ADP pocket N62A 66 NA NA þ NA Purine ring
Y65A    NA NA þþ Purine ring, ribose O2 H-bond
R99A      þ NA þ a-Phosphate H-bond
F113A 66 NA NA þ NA Phosphate contact; position AvrB R99 and
R266
Interlobe Y131A      þ þþ b-Phosphate (via H2O)
D297A      þ þþ Purine ring, ribose O3 (via H2O)
aContacts both RIN4142–176 or ADP in the crystal structures.
NA, not attempted.
doi:10.1371/journal.ppat.0030048.t002
Figure 3. ITC Data for Binding of RIN4 to Wild-Type AvrB and Selected AvrB Mutants
Fitted lines are shown for AvrB and mutants derivatives that did bind RIN4 (wild-type AvrB with full-length RIN4, wild-type AvrB with RIN4142–176 and
AvrB
QRY/AAA to RIN4142–176). Raw data are displayed for AvrB mutants that did not bind RIN4142–176. Lack of binding was verified by using 53 to 103
concentrations of RIN4142–176 and AvrB variant relative to concentrations of wild-type components.
doi:10.1371/journal.ppat.0030048.g003
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acid (EDTA) and heat denaturation of the plant extract by
boiling prior to assays, suggesting that AvrB phosphorylation
requires cations and a heat-labile plant factor (unpublished
data). Phosphorylation activity was speciﬁc for AvrB, the only
member of this type III effector family demonstrated to
trigger RPM1 function, since related paralogs (Figure 5C) did
not or only weakly incorporated radiolabeled phosphate
(Figure 5A). In this assay, AvrB phosphorylation appears to be
RIN4 independent, as it occurs in extracts from rin4 rpm1 rps2
mutant plants (unpublished data). Titrating increasing
amounts of puriﬁed full-length RIN4 protein into extracts
from rin4 rpm1 rps2 did not alter the level of AvrB
phosphorylation in vitro (unpublished data). Furthermore,
phosphorylation of AvrB does not require RIN4 binding,
since AvrB
QRY/AAA
, AvrB
T125A, and AvrB
H217A were readily
phosphorylated (Figure 4A). These data show that RIN4 is not
the plant cofactor that either directly or indirectly regulates
AvrB phosphorylation in planta.
In contrast, AvrB residues that directly contact ADP are
important for phosphorylation (Figure 5A). AvrB
R266A and
AvrB
Y65A were partially and completely compromised for
phosphorylation, respectively (Figure 5A). The requirement
of ADP interacting residues for AvrB phosphorylation
suggests that nucleotide binding by AvrB is critical for this
event. On the other hand, AvrB
Y131A and AvrB
D297A were
phosphorylated to the same levels as wild-type AvrB (Figure
5A). This correlates with the minor contribution of these
residues to nucleotide binding observed from the crystal
structure. Nevertheless, AvrB Y131 and D297 are required for
the triggering of RPM1 (Figure 4), suggesting their involve-
ment in another aspect of AvrB activation.
Discussion
Our data signiﬁcantly extend previous observations deﬁn-
ing the key functional regions of the type III effector protein
AvrB: its upper lobe and interlobal cleft mediate contact with
Figure 4. Interactions with RIN4 and ADP Are Required for AvrB Function in Activating RPM1
(A) Trypan blue staining of Arabidopsis Col-0 (RPM1) leaves 5 h after infection with Pto DC3000 expressing wild-type or mutant versions of HA-epitope
tagged AvrB. EV is an empty vector (pBBR1 MCS-2) used as a negative control in Pto DC3000. QRY/AAA is a triple mutation of AvrB Q208, R209, and Y210
to alanine. Trypan blue staining of five infected leaves per construct was repeated twice in two independent experiments, and two representative
leaves per AvrB mutant are presented.
(B) Quantification of HR by electrolyte leakage (mean 6 2 SE) from leaves infected with Pto DC3000 expressing AvrB and mutant derivatives as labeled.
The experiment was performed as in (A) and was repeated twice with similar results. Solid black lines represent the negative Pto DC3000(EV) (black
triangles) and positive controls Pto DC3000(avrB-HA) (black diamonds). In the top graph, hatched lines represent mutations of AvrB residues making
contacts with RIN4142–176 from the crystal structure presented in Figure 2. In the bottom graph, dotted lines represent mutations of AvrB residues lining
the ADP binding pocket, from the crystal structure presented in Figure 2.
(C) Growth of Pto DC3000 expressing the wild-type or selected alanine mutant versions AvrB-HA on Arabidopsis Col-0(RPM1). White and black bars
represent the bacterial populations at the time of inoculation (day 0) and 3 d postinoculation (day 3), respectively. Bars indicate the mean of four
samples 6 2 SE and are representative of two independent experiments.
doi:10.1371/journal.ppat.0030048.g004
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Plant Immune System Effector Recognitionthe Arabidopsis target protein RIN4, and the lower lobe
contains a pocket suitable for binding ADP or another
similarly shaped molecule (Figure 5B). We deﬁned three
correlates for triggering AvrB-dependent, RPM1-mediated
disease resistance function in Arabidopsis. These are AvrB’s
interaction with RIN4, its binding of nucleotide, or another
small molecule of similar shape, and its likely phosphoryla-
tion in the presence of Arabidopsis extract.
Our structure-based functional analysis of the AvrB-
RIN4142–176 complex identiﬁed two main regions of inter-
action: AvrB T125 and H217 and AvrB Q208, R209, and Y210.
These AvrB residues interact with bulky and aromatic RIN4
residues Y165, T166, H167, and F169 (previously termed the
AvrB binding site [BBS] [15]) in a ring-stacking arrangement
just C-terminal to the previously identiﬁed AvrRpt2 cleavage
site (RCS2; [14,15]). Mutation of these AvrB residues
interferes with the ability to trigger RPM1 function,
demonstrating that physical interaction of AvrB with RIN4
is required for recognition by RPM1. AvrB residues Q208,
R209, and Y210 are poorly conserved in other AvrB family
members (Figure 5C), suggesting that it might be the
speciﬁcity determinant for RIN4 binding.
The BBS and RCS are a functional, bipartite domain in
RIN4 and approximately 11 additional proteins in Arabidopsis
proteins (pfam05627). This RCS-BBS domain is widely
distributed in multicellular plants evolutionarily distant from
Arabidopsis, such as the moss Physcomitrella patens and the fern
Cerapteris richardii (http://plantta.tigr.org) and thus may have
conserved roles in the plant immune system. Within this
domain, the RCS is highly conserved, while the BBS and the
spacing between the RCS and the BBS is more variable. A
number of other RCS-BBS proteins are cleaved by AvrRpt2
(which targets the RCS [14,15]), yet it remains to be seen
whether the additional 11 BBS-containing proteins are also
bound by AvrB. It is noteworthy that the N-terminal RCS-BBS
domain of RIN4 does not bind AvrB [15], suggesting that the
amino acid divergence between the N-terminal RCS-BBS and
C-terminal RCS-BBS sequences of RIN4 is functionally
relevant.
AvrB is also recognized by a second resistance gene, Rpg1-b,
in soybean [19]. A random mutational analysis of AvrB
identiﬁed nine individual amino acids required for induction
of both RPM1-mediated HR on Arabidopsis and Rpg1-b
function on soybean [20]. Among these, AvrB T125, Q164,
and I215 were required for the HR phenotypes on both
RPM1-expressing Arabidopsis and Rpg1-b–expressing soybean.
All of these residues are in the AvrB upper lobe. The
hydrophobic I215 lies underneath T125, and its mutation
would likely disrupt the structural integrity of this region,
and hence interaction with RIN4. Q164 is not solvent exposed
and is also likely to disrupt AvrB structure when mutated.
S268 is also in the lower lobe, and its substitution to
isoleucine abrogated RIN4 binding in yeast two-hybrid assays
[20]. The polar side-chain of S268 is partially buried and its
mutation to a residue with a bulkier, nonpolar side-chain
could have detrimental effects on the structure of AvrB, thus
resulting in loss of RIN4 binding. A RIN4 ortholog is present
in soybean and possesses an intact BBS domain. Whether this
soybean RIN4 ortholog interacts with AvrB and is required
for Rpg1-b–mediated resistance remain to be determined.
We also observed binding of ADP to the lower lobe pocket
of AvrB (Figures 2 and 5B). Nucleotide contact residues (AvrB
Y65, R99, and R266) are conserved between AvrB family
members (Figure 5C) and are required for RPM1-mediated
disease resistance responses. Thus, the ability of AvrB to
trigger RPM1 function in Arabidopsis requires both interac-
tion with RIN4 and an intact nucleotide binding pocket.
Strikingly, Rpg-1b–mediated HR in soybean also required an
intact AvrB nucleotide-binding pocket [20]. In these studies,
AvrB
R266A did not elicit an HR in soybean. In addition, AvrB
G46 and A269, which make contacts with ADP in our crystal
structure, were also required for this activity in soybean [20].
We hypothesize that AvrB binds to ADP, or another
similarly shaped nucleotide, and interacts with RIN4 to
induce RIN4 phosphorylation in Arabidopsis. If so, then AvrB
might have a kinase or protokinase activity required to
phosphorylate RIN4. Tertiary structure-matching programs
such as DALI or MSD-Fold did not reveal signiﬁcant
structural similarity between AvrB and known kinases.
However, the AvrB structure is similar to typical Ser/Thr
protein kinases such as cAMP-dependent kinase, in that both
contain a bilobal structure with a large lobe composed
predominantly of alpha-helices and a small lobe with a mixed
alpha-helix beta-sheet content [18]. We present a model of a
ternary AvrB/RIN4/ADP structure created by superimposing
the AvrB/RIN4 and AvrB/ADP coordinates and subsequent
insertion of the ADP coordinates into the AvrB/RIN4
structure (Figure 6A). In this model, the distance between
the oxygen atoms of the beta-phosphate of ADP and the T166
Oc atom is quite short (4.2 A ˚ ), indicating that RIN4 T166 is a
strong candidate for phosphorylation by AvrB.
We compared our modeled ternary complex to the
structure of a ternary complex between cAMP-dependent
kinase, AMPPNP, and an inhibitor peptide in which the
acceptor serine 17 is replaced by an alanine [21] (Figure 6B).
This comparison revealed that AvrB residues necessary to
Figure 5. AvrB Is Specifically Phosphorylated in the Presence of Arabidopsis Extracts
(A) Amino acids critical for AvrB function are required for its phosphorylation in the presence of Arabidopsis extract. Autoradiograph of reaction mixtures
containing Arabidopsis (Col-0) extracts and [c-
32P]ATP with purified AvrB (36 kDa), indicated AvrB mutants, AvrB paralogs AvrC (39 kDa) and AvrXccC (36
kDa), or molecular weight markers (M). AvrB
R209A, AvrB
D297A, and AvrB
R266A include 14 additional amino acids from the recombination sequence of the
Gateway cloning vectors at their C terminus (approximately 2 kDa). The lane labeled AvrB( ) does not contain plant extract. Coomassie brilliant blue
staining of the radioactive gel, shown below, serves as a loading control.
(B) Two surface representations of AvrB bound to RIN4142–176 (left) and ADP (right). Red and yellow patches represent full and partial loss of AvrB
function with respect to triggering RPM1, respectively. RIN4142–176 is colored green, and amino acids making contacts with AvrB are highlighted (left).
ADP is shown as a space-filled molecule (right).
(C) AvrB residues contacting ADP are conserved among proteins of the AvrB protein family, but those contacting RIN4142–176 are not. Amino acid
sequence alignment of ten AvrB paralogs. Helices, strands, loops, and unstructured regions are denoted by red tubes, blue arrows, gray lines, and
dashed gray lines, respectively. Secondary structure elements from residues 16 to 27 are rendered transparent, as they have been observed in the AvrB/
ADP, but not in AvrB/RIN4142–176 or free AvrB (PDB code 1NH1). Residues marked by green and yellow circles make contact with RIN4142–176 or line the
ADP-binding cavity, respectively. The paralogs used in this alignment are from P. syringae pv. glycinea (AvrB, AvrC), P. syringae pv. phaseolicola (AvrPphC,
AvrB2, AvrB4–1, AvrB4–2), Xanthomonas campestris pv. campestris (AvrXccC), P. syringae pv. syringae (AvrB Psy1, AvrB Psy2, AvrB3).
doi:10.1371/journal.ppat.0030048.g005
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residues critical for the kinase activity of this cAMP-depend-
ent kinase. Also, the positions of the phospho-acceptor in the
inhibitor peptide and the putative acceptor T166 of RIN4 are
similarly positioned. In cAMP-dependent kinase, the nucleo-
tide binds in a cavity between the small lobe and large lobe,
with the small lobe making up the majority of the
interactions, whereas in AvrB the nucleotide binds in the
major cavity of the large lobe. As a result, the orientation of
the nucleotide is different between the two structures.
In cAMP-dependent kinase D168 deprotonates the accept-
or serine/threonine residue and T201 positions D168 by
hydrogen bonding. A similar role can be envisioned for AvrB
H217 and T125, respectively, with regard to the putative
acceptor T166 of RIN4. In addition, cAMP-dependent kinase
K72 plays a role in phosphate binding and in stabilization of
the transition state. It is analogous in position to R99 in AvrB.
Although R266 in AvrB could also play this role, this residue
is spatially most similar to D184 in cAMP-dependent kinase,
which is involved in ligating a Mn
2þ ion that chelates the
terminal phosphate group. In the AvrB/ADP structure, we
could not deﬁnitively observe a Mg
2þ ion. The mechanism of
metal binding in AvrB complexes remains to be elucidated.
Finally, protein kinases contain an activation loop joining
the two lobes whose phosphorylation is necessary for protein
kinase activity. In cAMP-dependent kinase, phosphorylation
of T197 in the activation loop (residues 191 to 199) is
necessary for kinase activity. In AvrB, residues 115 to 121
could form the activation loop, and three residues in this loop
(T118, S119, and T121) could serve as phosphorylation sites.
Additionally, this loop also borders the region (residues 120
to 125) that forms an antiparallel beta-sheet with residues 166
to 171 of RIN4. Hence, phosphorylation of this loop region
may also affect RIN4 binding.
Despite this plausible similarity to kinases, pure AvrB
neither autophosphorylates nor transphosphorylates pure
RIN4 in vitro (unpublished data). However, we found that
AvrB is phosphorylated in the presence of Arabidopsis extracts,
suggesting that AvrB’s possible kinase activity would require
accessory plant factors. In vitro, this phosphorylation event is
RIN4 and RPM1 independent. The P. syringae type III effector
avirulence protein Pseudomonas tomato (AvrPto) is also
phosphorylated in the presence of plant extracts independ-
ently of its corresponding plant disease resistance proteins,
Pto and Prf [22]. Additionally, NopL and NopP are TTSS
effector proteins from Rhizobium sp. NGR234 that are
phosphorylated in the presence of protein extracts from L.
japonicus [23,24]. Hence, there is a class of type III effector
proteins that are phosphorylated once delivered to the host
cell. We anticipate that this modiﬁcation is linked to effector
activation in all of these cases.
AvrB phosphorylation in the presence of Arabidopsis extract
is dependent on the AvrB nucleotide-binding residues we
deﬁned, such as Y65 and R266. While nucleotide binding
residues are required for AvrB to be phosphorylated, they are
not sufﬁcient, because AvrC and Xanthomonas campestris
campestris avirulence protein (AvrXccC) encode the con-
served nucleotide-binding region and are not phosphorylated
in the presence of Arabidopsis extract. These data suggest that
nucleotide bound to AvrB is required for the recruitment
and/or function of a host kinase. Alternatively, AvrB could act
as a ‘‘protokinase’’ that lacks intrinsic phosphor-transfer
activity that can be enhanced by association with plant
accessory protein(s). We speculate that each AvrB family
member has evolved to usurp a plant species-speciﬁc protein
that contributes to their activation by phosphorylation
following delivery into host cells.
The ability of AvrB to trigger RPM1 function requires its
nucleotide-binding pocket, which in turn is required for AvrB
phosphorylation induced by an unknown Arabidopsis cofac-
tor(s) or kinase, and interaction with RIN4. Neither AvrB
Y65A,
AvrB
Y131A, nor AvrB
D297A nor bound RIN4 in ITC (Figure 3),
although all three did in gel ﬁltration and/or yeast two-hybrid
assays (Table 2). The most parsimonious explanation for these
binding data requires very slow association and dissociation
rates of complex formation for AvrB and RIN4. For the wild-
type proteins, these slow rates result in a modest equilibrium
(kd approximately 1 lM) measurable by ITC and sufﬁcient for
isolation of AvrB–RIN4 complexes when the two proteins are
incubated together prior to gel ﬁltration chromatography.
Figure 6. Functionally Important Residues of AvrB Correspond to Catalytic Residues in Ser/Thr Protein Kinases
(A) A model of a possible ternary AvrB/RIN4142–176/ADP complex based on the crystal structures of AvrB/ADP and AvrB/RIN4142–176 (see Discussion).
(B) The crystal structure of a ternary complex of cAMP-dependent kinase/inhibitor peptide/AMPPNP (PDB code 1CDK). The color scheme employed
follows that of previous ribbon diagrams. RIN4142–176 and inhibitory peptide are shaded green in (A) and (B), respectively. Atoms of ADP and RIN4142–176
T166 in (A) and AMPPNP in (B) are colored by type: C (green), N (blue), O (red), and P (pink). Labeled residues are stick representations of those critical
for AvrB/RIN4142–176 or AvrB/ADP interaction in (A), and those critical for S17 phosphorylation, inhibited by S17A, as shown in (B).
doi:10.1371/journal.ppat.0030048.g006
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coexpressed during yeast two-hybrid analysis. We propose,
however, that AvrB
Y65A, AvrB
Y131A, and AvrB
D297A preferen-
tially decrease the on-rate for AvrB–RIN4 complex forma-
tion. Hence, complexes could still form and be isolated by gel
exclusion chromatography or inferred from yeast two-hybrid
data due to the very slow off-rate. However, the resulting
decrease in the overall equilibrium constant would prevent
accurate afﬁnity measurement by ITC. Implicit in this model
is the likely requirement for a conformational change in AvrB
that is slow and required prior to the binding of RIN4.
Importantly, Y131 and D297 reside at the interlobal boundary
of AvrB, and their substitution can easily be envisaged to shift
the conformational equilibrium of AvrB and lock it in a state
unfavorable for RIN4 association. This interpretation is
consistent with the ﬁnding of Ong and Innes (2006) that
AvrB
D297A enhanced binding of AvrB to RIN4 in their yeast
two-hybrid system.
Our data are consistent with the activity of the AvrB
protein family (Figure 5D). None of the AvrB homologs
induce RPM1 function, although the Xanthomonas campestris
protein AvrXccC interacts with RIN4 in yeast two-hybrid
experiments and binds RIN4 weakly in vitro (unpublished
data). Most of the AvrB-RIN4 contact residues are poorly
conserved, particularly those in a6 and a7 helices, including
AvrB Q208, R209, and Y210, which support the ring-stack of
RIN4. For example, these AvrB residues correspond to AvrC
residues A239, A240, and S241. AvrB T125, located on b1, is
essential for RIN4 interaction and is conserved in all
homologs of AvrB. Hence, the regions of AvrB that support
the ring-stack of RIN4 appear to contribute to the functional
speciﬁcity of AvrB for RIN4-dependent, RPM1-mediated HR.
By contrast, the important ADP-contacting residues Y65, R99,
and R266 in the lower lobe pocket are conserved in all AvrB
homologs, suggesting that nucleotide binding is a core
function for this entire type III effector family. However, an
intact ADP binding cavity is not sufﬁcient for phosphoryla-
tion of AvrB by Arabidopsis extracts, since the AvrC and
AvrXccC possess them (including N62 and F113) but are not
readily phosphorylated (Figure 5A). Furthermore, while
AvrXccC interacts with RIN4, at least in yeast, and possesses
the nucleotide-binding pocket, it does not trigger RPM1. This
suggests that RIN4 interaction and nucleotide binding are not
sufﬁcient for the activation of RPM1 by AvrB family
members.
AvrB Y131 and D297 are 4 A ˚ away from the nucleotide
binding site and are located in the solvent-exposed region of
the interlobe cleft. Many of the solvent-exposed residues of
the interlobe cleft are highly conserved within the AvrB
family (Figure 5C). The electrostatic surface of the interlobe
cleft and the sheer size of the cleft highly suggest that this
might be an active site required for an as-yet-undeﬁned
activity of AvrB, or for the docking of an Arabidopsis protein
that is required for AvrB phosphorylation. We speculate that
the divergent sequences of the AvrB paralogs, centered on
the interlobe cleft, are critical for recruitment of plant
species-speciﬁc cofactors that enhance nucleotide turnover
on each AvrB family member and/or align substrates of AvrB
with potential catalytic residues in the cleft. We speculate
that this set of atomic events would be required to trigger
RPM1 (or other NB-LR) function in diverse plant species.
Besides acting as an avirulence factor to trigger resistance
in Arabidopsis and soybean, AvrB can also serve as a virulence
factor in susceptible hosts. In the absence of a functional
Rpg1-b gene, AvrB enhances the growth of P. syringae on
susceptible soybean cultivars [19] Similarly, AvrB also induces
a cytotoxic yellowing response on Arabidopsis plants lacking
RPM1 that is attributable to either its function in virulence or
a weak disease resistance response [17]. Mutation of AvrB
T125, R266, or S268 to alanine abrogated the virulence
phenotype in soybean and compromised the chlorosis
phenotype in Arabidopsis [20]. Combined with our structural
data, these results indicate that RIN4- and ADP-binding
regions, as well as functions provided by the interlobe cleft,
are required for the virulence activity of AvrB. Therefore,
interaction with RIN4, nucleotide binding, and host phos-
phorylation are correlated with both the virulence activity of
AvrB and for its recognition by independent plant NB-LRR
proteins. This corroborates the ‘‘guard’’ model hypothesis
where NB-LRR proteins monitor the activity of type III
effectors for recognition rather than direct interaction [4,6].
Our three-dimensional crystal structures of AvrB in
complex with its host target RIN4 or the ADP, and the
combined functional studies detailed here and in Ong and
Innes (2006), suggest a plausible series of events required for
both AvrB virulence activity on susceptible hosts and for its
ability to trigger disease resistance recognition in two plant
species: AvrB is delivered by the TTSS of Pto DC3000. Inside
the host cell, AvrB binds to a nucleotide, or another small
molecule of similar shape. The AvrB–nucleotide complex
recruits a plant cofactor that transforms AvrB into a kinase
capable of autophosphorylation. Alternatively, the nucleo-
tide-bound form of AvrB mimics a substrate for an unknown
plant kinase and becomes phosphorylated itself. Because
soluble AvrB can be labeled in an Arabidopsis extract, we infer
that phosphorylation of AvrB is independent of, and hence
might precede, myristoylation and plasma membrane local-
ization [17]. Phosphorylated AvrB becomes myristoylated and
directed to the plasma membrane. At the plasma membrane,
AvrB interacts with RIN4, and its conformation is altered.
This stable heterodimer guides RIN4 phosphorylation. The
AvrB–RIN4 complex, and potentially the phosphorylated
form of RIN4 itself, triggers RPM1-mediated activation of
disease resistance. RIN4 functions as a negative regulator of
basal defense [25]. Hence, in the absence of RPM1, AvrB is
similarly activated and subsequently interacts with, and
indirectly induces post-translational modiﬁcations of RIN4
and other BBS-containing proteins [15] in order to curb basal
defense responses and contribute to disease.
Materials and Methods
Construction of clones and mutants. For expression in P. syringae,
AvrB-HA downstream of the AvrRpm1 promoter [17,26] was
constructed by PCR ampliﬁcation using primers that incorporated
an XhoI site upstream of the AvrRpm1 promoter (XhoI-AvrRpm1p)
and a BamHI site downstream of the HA epitope tag (BamHI-HA).
The resulting PCR product was digested with the restriction enzymes
XhoI and BamHI and cloned into the broad host range vector pBBR1
MCS-2 [27] digested with the same enzymes. Mutations of AvrB were
generated by PCR using PFU turbo high-ﬁdelity polymerase
(Stratagene, http://www.stratagene.com). Overlapping primers incor-
porating the mutation of interest were synthesized, and PCR was
conducted using the sense primer with BamHI-HA and the antisense
primer with XhoI-AvrRpm1p. The resulting PCR products were gel
puriﬁed, combined, and used as a template for a second PCR using
the XhoI-AvrRpm1p and BamHI-HA primers. The resulting PCR
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http://www.invitrogen.com) and sequenced to ensure that no addi-
tional mutations had been introduced. The insert was then cleaved
using the restriction enzymes XhoI and BamHI and cloned into
pBBR1 MCS-2 digested with the same enzymes. pBBR1 MCS-2
containing the mutant AvrB-HA genes were then introduced into
Pto DC3000 by triparental mating.
AvrB alleles from X. campestris pv. campestris strain 8004 (Xcc), P.
syringae pv. glycinea race 0 (AvrC), and P. syringae pv. syringae strain
B728A were PCR ampliﬁed from the corresponding bacterial strains
and cloned into TOPO-TA (Invitrogen) cloning vectors (Z. Nimchuk
and J. L. Dangl, unpublished data). To add an N-terminal glutathione-
S-transferase (GST) tag, alleles were PCR ampliﬁed from TOPO-TA
vectors using oligonucleotides that incorporated an N-terminal TEV
cleavage site and subcloned into the pENTR D-TOPO vector
(Invitrogen). The genes were then recombined into pDEST-15 vector
using the LR Clonase enzyme mix according to manufacturer’s
instructions (Invitrogen). Similarly, mutated versions of AvrB were
ampliﬁed from TOPO-TA and subcloned into pENTR D-TOPO
followed by recombination into pDEST15 using LR recombination
enzymes (Invitrogen).
Protein expression and puriﬁcation. AvrB in pProEX-HTa was
induced with 0.75 mM isopropyl-b-D-thiogalactopyranoside (IPTG) at
18 8C for 6 h in BL21 Rosetta cells (Stratagene). All protein
puriﬁcation steps were performed at 4 8C. Cell pellets were
resuspended in buffer A (20 mM Tris [pH 8.0], 300 mM NaCl, and
10 mM imidazole) plus one ‘‘Complete EDTA-free’’ protease inhibitor
tablet (Roche, http://www.roche.com), a few crystals of Lysozyme
(Sigma, http://www.sigmaaldrich.com), and DNase (Sigma). After
resuspension, cells were lysed using an Avestin Emulsiﬂex-C5
(Avestin, http://www.avestin.com) and centrifuged for 45 min at
15,000 rpm in an SS-34 rotor. The supernatant was loaded on to a 5
ml High Trap chelating column (GE Healthcare, http://www.
gehealthcare.com) preloaded with nickel as described in the
manufacturer’s instructions. The column was then washed with 10
column volumes of buffer A, followed by 10 column volumes of buffer
A augmented with 50 mM imidazole. Speciﬁc elution of AvrB was
performed with 5 column volumes of buffer A containing 400 mM
imidazole. Relevant fractions were pooled and dialyzed overnight at 4
8C in low-salt buffer containing 20 mM Tris (pH 8.0) and 100 mM
NaCl in the presence of tobacco etch virus (TEV) protease to
facilitate removal of N-terminal His tags. Removal of tags was veriﬁed
by SDS-PAGE. The dialysate was loaded on an 8-ml Source Q (GE
Healthcare) anion exchange column and eluted with a 0 to 400 mM
NaCl gradient. If samples were not sufﬁciently pure at this point,
relevant fractions were concentrated to approximately 10 ml and
applied to a HighPrep 26/20 Sephacryl S200 (GE Healthcare) column
equilibrated with 20 mM HEPES (pH 7.5), 150 mM NaCl, and 1 mM
DTT. Puriﬁed protein was exchanged into 20 mM Tris (pH 8.0), 50
mM NaCl, and 3 mM DTT; concentrated to approximately 20 mg/ml
and ﬂash-frozen using liquid N2; and stored at  80 8C.
All AvrB mutants were cloned into the PD15 plasmid (GATEWAY;
Invitrogen) and thus isolated as TEV-cleavable GST fusions.
Induction was also performed with 0.75 mM ITPG at 18 8C for 6 h
in BL21 Rosetta cells (Stratagene). Cell pellets were resuspended in
buffer B (20 mM Tris [pH 7.5], 300 mM NaCl, and 1 mM DTT) and
lysed as described for wild-type AvrB. Clariﬁed lysates were loaded on
a 5-ml High Trap glutathione column (GE Healthcare). The column
was then washed with 10 column volumes buffer B, followed by
speciﬁc elution by 3 to 5 column volumes of buffer B plus 10 mM
glutathione. Eluted protein was digested overnight at 4 8C with TEV
protease, and completely digested protein was diluted 5-fold, loaded
on an 8-ml Source Q column, and eluted with a 0 to 400 mM NaCl
gradient. Relevant fractions were then concentrated to less than 1 ml,
ﬂash-frozen in liquid N2 in approximately 250-ll aliquots, and stored
at  80 8C.
RIN4 was cloned into pGEX-6P-1 as a GST-fusion cleavable with
PreScission protease (GE Healthcare) and expressed in RIL codon-
plus cells (Stratagene). Cells were grown to an OD of approximately
0.4 at 37 8C, and then the temperature was decreased to 25 8C for 45
min, and cells were induced for 3 h with 0.5 mM IPTG. Cell pellets
were resuspended in buffer C (20 mM sodium phosphate [pH 6.5], 2
mM DTT, 1 mM EDTA) plus one ‘‘Complete EDTA-Free’’ protease
inhibitor tablet (Roche), a few crystals of Lysozyme (Sigma), and
DNase (Sigma). Cells were lysed as described for AvrB. Clariﬁed
lysates were then loaded on a hand-poured 20-ml Fast Flow S (GE
Healthcare) column, washed with low-salt buffer, and then eluted
with a 20 column volume gradient of buffer C plus 0 to 500 mM NaCl.
The resulting broad peak was concentrated to 50 ml, 50 units/ml
PreScission protease was added, and the mixture was dialysed
overnight into buffer D (20 mM HEPES [pH 7.5], 50 mM NaCl, 2
mM DTT). Completely digested protein, as veriﬁed by SDS-PAGE, was
then loaded on a 8-ml Source S column (GE Healthcare) and eluted
with a 0 to 400 mM NaCl gradient. Relevant fractions were then
pooled and again dialyzed overnight in buffer C. The dialysate was
then run on a 8-ml Source Q column (GE Healthcare) and eluted with
a 0 to 400 mM NaCl gradient. The purity of the samples was veriﬁed
by SDS-PAGE, concentrated to approximately 2.5 mg/ml, ﬂash-frozen
in liquid N2 in approximately 250-ll aliquots, and stored at  80 8C.
Gel ﬁltration. Gel ﬁltration experiments of the mutant AvrB
proteins were performed by loading approximately 0.3 to 0.5 mg of
protein either alone or with roughly equimolar RIN4 in a volume of 1
ml onto a hand-poured calibrated 16/70 Superdex S-75 column. Flow
rate was 0.9 ml/min, and 3-ml fractions were collected from 30 to 80
ml over a 150-ml run.
Circular dichroism. Circular dichroism experiments were run on a
Pistar-180 Circular Dichroism/Fluorescence spectrophotometer (Ap-
plied Photophysics, http://www.photophysics.com). Samples at ap-
proximately 0.1 mg/ml were exchanged into a buffer containing 20
mM potassium phosphate (pH 7), and placed in a 0.1-cm cuvette, and
scans were taken from 185 to 260 nm with 0.2-nm increments and
30,000 repetitions per increment.
Isothermal titration calorimetry. ITC experiments were performed
on a VP-ITC microcalorimeter (MicroCal, http://www.microcalinc.
com). To verify binding, we used concentrations of wild-type and
variant AvrB ranging between 5 and 25 lM AvrB. RIN4142–176 peptide
with concentrations ranging from 50 to 450 lM was titrated in 6-ll
injections with stirring at 255 rpm. Experiments involving wild-type
AvrB and full-length RIN4 used 6 lM and 120 lM, respectively. Once
binding was conﬁrmed (for wild-type and QRY/AAA), experiments
were repeated in triplicate. Nonbinding was conﬁrmed by increasing
the concentrations of both the proteins to as much as 25 lM and 450
lM, respectively. Nonbinding variants were conﬁrmed by repeating
the experiment twice. Thermodynamic parameters were ﬁt to the
data using Origin v 7.0383 software (OriginLab, http://www.originlab.
com).
Crystallization. Conditions for crystallization of AvrB and AvrB/
RIN4142–176 were similar to those reported for AvrB previously [18].
Free AvrB was crystallized by vapor diffusion at 4 8C of a 1:1 mix of
protein (8 to 10 mg/ml) with well solution (100 mM glycine [pH 9.0],
20% to 30% polyethylene glycol 550 monomethyl ether [PEG 550
MME]). AvrB/RIN4142–176 was also crystallized by vapor diffusion at 18
8C of an approximately 1:2 to 3 ratio of protein to peptide, mixed
with an equal volume of well solution (100 mM Tris [pH 7.5], 20% to
30% PEG 550 MME). Initial crystals were of poor quality and were
heavily twinned. This crystalline mass was resuspended in 50 ll of well
solution, broken up and serially diluted 10-, 100-, and 1,000-fold, and
used for microseeding. In general, seeds yielded suitable quality
crystals within 2 d. AvrB/RIN4142–176 crystals belonged to space group
P2(1) with cell dimensions a¼45.9 A ˚ ,b¼58.2 A ˚ ,c¼119.8 A ˚ , and b¼
89.98, which corresponds to a very different packing than the P6(5)
crystals found for crystals of free AvrB [18]. Soaks of nucleotide were
performed by exchanging drop and reservoir solutions with 20 llo f
27% PEG 500 MME and 100 mM Tris 7.5 (with and without 5 mM
MgCl2), followed by a ﬁnal exchange in the drop of this solution plus
5 mM nucleotide. Nucleotides were soaked for approximately 1 d.
Following soaks, crystals were found to pack in the P6(5) space group,
with cell dimensions a¼b¼122.7 A ˚ ,c¼64.1 A ˚ , which is within 2.5 A ˚
of the cell dimensions reported for free AvrB [18]. All crystallization
solutions described in this section are inherently cryoprotective, and
no further cryoprotection was found to be necessary.
Diffraction and structure determination. AvrB/RIN4142–176 diffrac-
tion data were collected on a Rigaku RU-H3R (http://www.rigaku.com)
rotating anode generator equipped with Osmic confocal ‘‘blue’’
optics, and diffraction intensities were recorded on an R-Axis IVþþ
image plate system. For the ADP-soaked crystals, diffraction data
were collected at the SER-CAT beamline (ID-22; Advanced Photon
Source, http://www.aps.anl.gov). All structures were solved by molec-
ular replacement using AMoRe [28] using the previously solved free
AvrB structure (PDB code 1NH1) [18]. Upon molecular replacement
followed by rigid-body reﬁnement, simulated annealing, and individ-
ual B factor reﬁnement using CNS [29], difference electron density
could be found for both the peptide and nucleotide (see Figure 1A
and D). Peptide and nucleotide were then modeled into the resulting
difference density using the program O [30]. Deﬁnitions of ADP
torsions in O, as well as topology and parameter ﬁles for all
nucleotides, Tris, and triﬂuoroacetic acid, were taken from the Hic-
Up server (http://xray.bmc.uu.se/hicup). This was followed by iterative
cycles of simulated annealing, B factor reﬁnement, and water picking
to reach the results shown in Table S2. In addition, restrained 2-fold
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AvrB/RIN4142–176 structure. From two AvrB/RIN4142–176 complexes in
the asymmetric unit, 5,389 atoms are modeled, including residues 26
to 53 and 56 to 321 of AvrB and residues 150 to 172 of RIN4, in both
complexes. In addition, 325 water molecules, four Tris molecules, and
two triﬂuoroacetic acid molecules were included in the model. For
the AvrB/ADP structures, there are 1,503 atoms, including residues 16
to 319 of AvrB, 1 nucleotide, one Tris molecule, and 82 water
molecules.
Western blot analyses. For Western blot analyses, 1.5-ml overnight
cultures grown in KB with the appropriate antibiotics were pelleted,
washed with hrp gene-inducing minimal media [26], and resuspended
to an OD600 of 0.1 in minimal media. Then, 2.5 ml of the 0.1 OD600
culture was induced overnight and spun down the next day. Pellets
were resuspended in 250 ll of 20 mM Tris/HCl (pH 8.0) and sonicated
twice for 10 s with a 1-min interval between. The sonicated culture
was spun down at 4 8C for 20 min at 20,000g. Then, 200 ll of the
supernatant was removed carefully so as not to disturb the pelleted
and centrifuged again at 4 8C for 20 min. Next, 150 ll of the
supernatant was carefully removed and soluble protein quantiﬁed.
And 20 lg of protein of soluble protein from the wild-type and
mutant AvrB-HA expressing Pto DC3000 strains was loaded onto
SDS-PAGE gels after equalizing volumes with 20 mM Tris/HCl (pH
8.0), 63 Laemmli buffer was added, and it was boiled for 5 min.
Immunodetection was performed by standard methods using anti-HA
antibodies (Roche) at a dilution of 1:1,000.
Stains and cell death quantiﬁcation. Lactophenol–trypan blue was
used to visualize dead cells 5 h postinoculation with Pto DC3000
expressing wild-type and mutant AvrB-HA constructs as previously
described [31]. Electrolyte leakage assays were carried out as
previously described [31]. Brieﬂy, fully expanded leaves from 3-wk-
old plants were hand-inoculated with 0.1 OD600 (approximately 5 3
10
7 cfu/ml) Pto DC3000 DC3000 expressing wild-type or mutant AvrB-
HA constructs. At 2 h after infection, 7.5-mm leaf discs were collected
and washed extensively with distilled water for 1 h. Four leaf discs
were placed in a tube with 6 ml of distilled water (four replicates per
treatment), and conductivity was measured over time with a
conductivity meter (model 130; Orion Research, http://www.thermo.
com).
Kinase assays. Plant extracts were prepared by grinding two or
three 2-cm
2 leaves to a ﬁne powder in liquid nitrogen using a mortar
and pestle. Then, 1 ml of grinding buffer (20 mM Tris/HCl [pH 8.0], 50
mM NaCl, 0.01% Triton X-100, 5 mM DTT) was added to the powder
in a 1.5-ml microcentrifuge tube, and the mixture was vortexed for 30
s, followed by centrifugation for 10 min at 2,000g to remove large cell
debris. The supernatant was collected and used as total plant extract.
The 20-ll reactions contained 100 ng of puriﬁed AvrB allele or AvrB
mutant, 1 lg of plant extract, 10 lM[ c
32P]ATP (1.2 lCi; Amersham
Biosciences, http://www.amershambiosciences.com), 100 lM ATP, and
10 mM MgCl2. Reactions were allowed to proceed for 10 min and
terminated by adding 5 llo f5 3 Laemmli buffer and boiling for 5
min. Reactions were loaded onto 12% SDS-PAGE gels, and
incorporated radiolabel was visualized by autoradiography. As an
equal loading control for proteins used in the kinase reactions, the
SDS-PAGE gels were stained by Coomassie blue after detection.
In planta growth assays. Pto DC3000 strains containing the wild-
type or mutant AvrB-HA constructs were streaked out onto King’s
medium B (KB) plates containing the appropriate antibiotics and
incubated at 28 8C overnight. Bacteria were then scraped off the plate
and resuspended to an OD600 of 0.0002 (approximately 1 3 10
5 cfu/
ml) in 10 mM MgCl2. Three-week-old plants were hand-inoculated
with the diluted bacterial solution. Each sample was collected in
quadruplicate using four leaves for each time point (16 discs per time
point). Leaf discs were bored from the inﬁltrated area, ground in 10
mM MgCl2, and serially diluted to quantify bacterial numbers.
LexA yeast two-hybrid. For yeast two-hybrid analysis, avrB and its
mutant derivatives were cloned into the Gateway-compatible LexA
binding domain (BD) fusion vector pEG202 using LR Clonase II
enzyme mix (Invitrogen). The LR reaction was left to proceed
overnight at 16 8C. Yeast two-hybrid analysis was performed using the
MATCHMAKER LexA system (Clontech, http://www.clontech.com)
following the manufacturer’s protocols. The yeast strains used in this
study are EGY48 (Clontech) and RFY206. RIN4 was expressed from
the plasmid pJG4–5 as B42 activation domain (AD) fusions and
transformed into yeast strain EGY48 (MATa). avrB and its mutant
derivatives were expressed from plasmid pEG202 and transformed
into the yeast strain RFY206 (MAT a) carrying the lacZ reporter
plasmid pSH18–34 (þpSH18–34). Preparation of highly competent
yeast cells and small-scale lithium acetate transformations were
performed using the Frozen-EZ Yeast Transformation II Kit (Zymo
Research, http://www.zymoresearch.com). The RFY206 (þpSH18–34)
transformants carrying pEG202:AvrB and its mutants were selected
on minimal SD glucose agar base [0.7% yeast nitrogen base without
a m i n oa c i d sa n d2 %b a c t o - a g a rs u p p l e m e n t e dw i t h– U r a – H i s
Dropout (DO)] (Qbiogene, http://www.qbiogene.com). The EGY48
transformants expressing pJG4–5 containing RIN4 were selected on
minimal SD glucose agar base supplemented with –Trp DO
(Qbiogene). After plating, the plates were incubated for 3 to 4 d at
30 8C until colonies appeared.
Pairwise matings were set up between RFY206 (þpSH18–34):Lex-
ABD-avrB strains and EGY48:B42AD-RIN4 or EGY48:B42AD. The
standard yeast mating procedure was followed according to the
manufacturer’s protocols (Clontech Yeast Protocols Handbook). A
100-ll aliquot of the mating culture was spread on SD Glucose Agar
base supplemented with –Ura/–His/–Trp DO to select for diploids.
Plates were incubated at 30 8Cf o r3t o4dt oa l l o wy e a s t
cotransformants to form visible colonies. In the diploid strain, the
two reporters are LEU2 and lacZ. To assay for protein–protein
interactions, yeast cotransformants were replica plated onto two
different selective media containing galactose (Gal) to induce the
expression of B42AD-RIN4 protein. Plates were incubated at 30 8C
for 3 to 4 d until growth was detected.
1. SD Gal agar base supplemented with –Ura/–His/–Trp DO to
conﬁrm the nutritional phenotypes of the diploid by selecting for the
LexABD, B42AD, and pSH18–34 vectors.
2. SD Gal agar base supplemented with –Ura/–His/–Trp/–Leu/X-Gal
DO to screen for Leu2 and lacZ reporter gene expressions. Growth
and blue color were monitored based on activation of the reporter
genes and were scored as a positive interaction between the fusion
proteins. No interaction was scored if the replicates grew only on Gal/
SD/–Ura/–His/–Trp DO plate and not on agar base supplemented with
Gal/SD/–Ura/–His/–Trp/–Leu/X-Gal.
To determine LexABD-AvrB accumulation in yeast, RFY206 yeast
cultures were grown in selective medium overnight. The cultures
were diluted to an OD600¼0.15 – 0.2. The cultures were continuously
monitored until an OD600 of 0.4 to 0.6 was reached. The cells were
pelleted and proteins were extracted and boiled in 50 mM sodium
phosphate (pH 7.0), 25 mM 2-morpholinoethanesulfonic acid (MES)
(pH 7.0), 3 M urea, 1% SDS, 10% b-mercaptoethanol (BME), and 0.1%
Bromophenol Blue supplemented with Complete Protease Inhibitor
Pellets (Roche). The boiled samples were spun brieﬂy in the tabletop
centrifuge to pellet cell debris. A volume equivalent to 0.5 total OD600
was loaded into each well on a 10% SDS-PAGE gel. After electro-
phoresis, the proteins were transferred from the SDS-PAGE gel to
nitrocellulose membrane support. Western blots were done by
standard methods. Anti-LexBD antibody was used at 1:100 (Santa
Cruz Biotechnology, http://www.scbt.com). Detection of LexA-AvrB
was with the goat monoclonal antibody. Detection of the peroxidase
signal of the secondary antibody-HRP conjugate was performed with
ECL (Amersham Biosciences).
AvrRpt2 translocation assays. Selected AvrB mutants were fused to
D79AvrRpt2 by cloning into Gateway-compatible pBBR1-MCS2
[32,33] using LR clonase and transformed into Escherichia coli DH5a.
Each construct was introduced in Pto strain DC3000 by triparental
matings. Inﬁltrations of Arabidopsis rpm1–3 were done as described [9].
The HR was scored 24 h after Pto DC3000 inoculations. Results were
compared with leaves inﬁltrated with Pto carrying full-length avrRpt2
or an empty vector.
Supporting Information
Figure S1. AvrB Contacts with Main-Chain Residues of RIN4142–176
Antiparallel beta-strand hydrogen-bonding interactions between
main-chain residues of RIN4142–176 with AvrB, as well as a hydrogen
bond between the main-chain of the RIN4142–176 and the guanidi-
nium group of R209 in AvrB. Stick representations of main-chain
residues from RIN4142–176 are labeled green. Main-chain residues of
AvrB contacting RIN4142–176 and the side-chain of R209 are labeled
blue. AvrB helices and strands are red and blue, respectively.
Found at doi:10.1371/journal.ppat.0030048.sg001 (48 KB PDF).
Figure S2. Functional Consequence of Additional AvrB Mutations of
RIN4142–176 Contact Residues and Residues in the ADP Binding
Pocket
(A) Quantiﬁcation of RPM1-dependent mediated cell death by
electrolyte leakage (mean 6 2 SE) of leaves infected with Pto
DC3000 expressing wild-type AvrB-HA or AvrB-HA mutants at
amino acids in the RIN4 binding groove. Positive and negative
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are represented by solid black lines and symbols as given, and
mutants with dashed lines and symbols as given.
(B) Quantiﬁcation of RPM1-dependent mediated cell death by
electrolyte leakage (mean 6 2 SE) of leaves infected with Pto
DC3000 expressing wild-type AvrB-HA or AvrB-HA mutants at
amino acids lining the ADP binding domain, done as in (A). Note that
N62A and F113A give intermediate levels of RPM1-mediated ion
leakage.
(C) Trypan blue staining of Arabidopsis Col-0 leaves 5 h after infection
with Pto DC3000 expressing wild-type or mutant versions of AvrB-
HA. Experiments presented in (A through C) were repeated twice
using ten leaves per AvrB allele for trypan blue staining and 12 leaves
per AvrB allele for ion leakage experiments. Note that N62A and
F113A give intermediate levels of RPM1-mediated trypan blue
staining.
(D) Western blot analysis of soluble protein from Pto DC3000
expressing wild-type or various mutant versions of AvrB-HA,
detected using anti-HA monoclonal antibody. Twenty micrograms
of soluble protein from Pto DC3000 expressing each construct and
grown in minimal media was loaded in each lane.
Found at doi:10.1371/journal.ppat.0030048.sg002 (191 KB PDF).
Figure S3. All Loss-of-Function AvrB Mutant Alleles Are Trans-
located into Plant Cells
Type III–dependent secretion was conﬁrmed for all loss-of-function
AvrB mutant alleles. Wild-type AvrB or AvrB mutants as listed were
independently expressed as N-terminal fusions to the C-terminal,
HR-inducing domain of AvrRpt2 (AvrRpt2:80–255) in Pto DC3000,
and inoculated onto Col-0 (rpm1) mutant plants. All avrB::avrRpt2:80–
255 strains triggered HR 20 h after inﬁltration. By contrast,
expression of AvrRpt2:81–255 in the absence of AvrB (EV, empty
vector control) did not induce RPS2-mediated HR (not shown).
Found at doi:10.1371/journal.ppat.0030048.sg003 (25 KB PDF).
Accession Numbers
Crystallographic coordinates are deposited at the RCSB Protein Data
Bank (http://www.rcsb.org/pdb) with the codes 2NUD and 2NUN for
the AvrB/RIN4 and AvrB/ADP complexes, respectively; and 1CDK for
inhibitor peptide in which the acceptor serine 17 is replaced by an
alanine. The GenBank (http://www.ncbi.nlm.nih.gov/Genbank) acces-
sion numbers for the paralogs used in Figure 5 are AvrB (P13835),
AvrC (P13836), AvrPphC (AAV68743), AvrB2 (YP_272229), AvrB4–1
(YP_275207), AvrB4–2 (YP_273068), AvrXccC (XCC2109), AvrB
Psy1 (AAN85189), AvrB Psy2 (AAF71496), and AvrB3 (YP_275207).
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